DOCSLIB.ORG

Expression and Function of TRPM3 Proteins in the Pituitary Gland of the Mouse

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expression and Function of TRPM3 Proteins in the Pituitary Gland of the Mouse FR 2.4 - Experimental and Clinical Pharmacology and Toxicology Faculty II – Medicine: Theoretical Medicine and Biosciences Universität des Saarlandes, Homburg / Saar Expression and function of TRPM3 proteins in the pituitary gland of the mouse Dissertation submitted to fulfill the requirements for the degree of Doctor rerum naturalium at UNIVERSITÄT DES SAARLANDES 2014 Submitted by: Nouma Hasan Born on: 08.3.1983 in Latakia, Syria First referee PD. Dr. Stephan Philipp Second referee Univ. Prof. Dr. Peter Lipp Homburg, August 2014 To my husband, my son my parents and beloved sister and brothers Acknowledgments I would like to express my great thanks to my supervisor PD. Dr. Stephan Philipp for the unlimited support throughout my PhD and the correction of this thesis. I thank him for his professional guidance and useful discussions and for challenging me to learn and to create my own ideas. I am also deeply grateful for his encouragement, patience and understanding. I am extremely grateful to Prof. Dr. Veit Flockerzi for providing me with his help and valuable discussions and ideas. I also thank him to give me the opportunity to work in his lab. I wish to thank Dr. Andreas Beck for performing the electrophysiological experiments involved in this work and for his help and discussion. I would also like to take the chance to thank Prof. Dr. Frank Kirchhof, Prof. Dr. Frank Schmitt and Prof. Dr. Ulrich Boehm to give me the opportunity to learn some techniques in their lab. Special thanks to Ute Soltek, Heidi Löhr, Karin Wolske and Martin Simon-Thomas for their technical assistance and help. I thank Sandeep Dembla and Julia Camacho Londoño for introducing me to various techniques I used to perform this work. I wish to thank all my colleges in the Experimental and Clinical Pharmacology and Toxicology and specially Thabet Belcacemi and Anour Belcacemi for their help and support. I wish to thank the graduate research school Calcium-signaling and cellular nanodomains at the University of Saarland for providing the opportunity to join the program. My sincere thanks go on my dear friend Dalia Al-ansary for her continuous and unlimited support and help and for being part of my family here in Germany. I thank Mahnaz Amini for being real friend for me. Last but not least, I thank my beloved Ossama for being always there to surround me with love, patience and optimism and my sweet Ammar who made our life always happy. Table of Content Table of content 1 Summary ........................................................................................................................................... 1 2 Introduction ........................................................................................................................................ 3 2.1 The pituitary gland .......................................................................................................................... 3 2.1.1 Anatomy and histology of the pituitary gland .............................................................................. 3 2.1.2 Regulation and function of hormone-releasing pituitary cells ..................................................... 5 2.1.2.1 Somatotrophs ........................................................................................................................... 5 2.1.2.2 Lactrotrophs ............................................................................................................................. 6 2.1.2.3 Gonadotrophs ........................................................................................................................... 6 2.1.2.4 Thyrotrophs .............................................................................................................................. 7 2.1.2.5 Corticotrophs ............................................................................................................................ 7 2.1.2.6 Melanotrophs ............................................................................................................................ 8 2.1.2.7 Oxytocin-releasing hypothalamic nerve terminals ................................................................... 9 2.1.2.8 Vasopressin-releasing hypothalamic nerve terminals .............................................................. 9 2.1.3 Function and regulation of non-endocrine pituitary cells ............................................................. 9 2.1.3.1 Pituicytes .................................................................................................................................. 9 2.1.3.2 Folliculostellate cells ............................................................................................................... 10 2.2 Calcium signaling in pituitary cells and regulation of hormone release ....................................... 11 2.3 TRP ion channels ......................................................................................................................... 12 2.3.1 Structure of TRP channel complexes ........................................................................................ 14 2.3.2 Activation and functional properties of TRP channels .............................................................. 17 2.4 Transient receptor potential Melastatin 3 (TRPM3) ..................................................................... 20 2.4.1 The Trpm3 gene encodes a variety of different TRPM3 proteins ............................................. 20 2.4.2 Expression and function of TRPM3 proteins ............................................................................. 23 2.4.3 Pharmacology of TRPM3 channels ........................................................................................... 25 2.5 Aim of the work ............................................................................................................................. 26 3 Materials .......................................................................................................................................... 27 3.1 Chemicals ..................................................................................................................................... 27 3.2 Reagent systems (Kits) ................................................................................................................ 27 3.3 Vectors ......................................................................................................................................... 27 3.4 Oligonucleotides ........................................................................................................................... 28 3.5 Primary and secondary antibodies ............................................................................................... 29 3.6 Bacterial strains ............................................................................................................................ 31 3.7 Mice .............................................................................................................................................. 31 Table of Content 4 Methods ........................................................................................................................................... 33 4.1 Molecular biological methods ....................................................................................................... 33 4.1.1 Cultivation and transformation of eukaryotic cells ..................................................................... 33 4.1.1.1 Cultivation of HEK 293 cells ................................................................................................... 33 4.1.1.2 Preparation and cultivation of primary pituitary cells .............................................................. 33 4.1.1.3 Transformation of eukaryotic cells ......................................................................................... 34 4.1.2 Cultivation and transformation of Escherichia coli .................................................................... 34 4.1.2.1 Cultivation of Escherichia coli ................................................................................................ 34 4.1.2.2 Preparation of electrocompetent E. coli cells ......................................................................... 34 4.1.2.3 Transformation of plasmid DNA into electrocompetent bacterial cells .................................. 35 4.1.3 Isolation and purification of nucleic acids .................................................................................. 35 4.1.3.1 Isolation of total RNA .............................................................................................................. 35 4.1.3.2 Analytical quick preparation of plasmid DNA for sequencing ................................................ 36 4.1.3.3 Electroelution of DNA fragments from agarose gels .............................................................. 36 4.1.3.4 Ethanol precipitation of nucleic acids ..................................................................................... 36 4.1.4 Analysis of nucleic acids ........................................................................................................... 37 4.1.4.1 Photometry ............................................................................................................................. 37 4.1.4.2 Gel electrophoresis of DNA .................................................................................................... 37 4.1.4.3 Gel electrophoretic analysis
Load more

Recommended publications
  • Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment. Author Cabanas, Helene, Muraki, Katsuhiko, Eaton-Fitch, Natalie, Staines, Donald Ross, Marshall- Gradisnik, Sonya Published 2021 Journal Title Frontiers in Immunology Version Version of Record (VoR) DOI https://doi.org/10.3389/fimmu.2021.687806 Copyright Statement © 2021 Cabanas, Muraki, Eaton-Fitch, Staines and Marshall-Gradisnik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Downloaded from http://hdl.handle.net/10072/406897 Griffith Research Online https://research-repository.griffith.edu.au ORIGINAL RESEARCH published: 13 July 2021 doi: 10.3389/fimmu.2021.687806 Potential Therapeutic Benefitof Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment Edited by: Helene Cabanas 1,2*, Katsuhiko Muraki 2,3, Natalie Eaton-Fitch 1,2, Donald Ross Staines 1,2 Jorge Matias-Guiu, 1,2 Complutense University and Sonya Marshall-Gradisnik
    [Show full text]
  • Unnatural Verticilide Enantiomer Inhibits Type 2 Ryanodine Receptor-Mediated Calcium Leak and Is Antiarrhythmic
    Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic Suzanne M. Batistea,1, Daniel J. Blackwellb,1, Kyungsoo Kimb,1, Dmytro O. Kryshtalb, Nieves Gomez-Hurtadob, Robyn T. Rebbeckc, Razvan L. Corneac, Jeffrey N. Johnstona,2, and Bjorn C. Knollmannb,2 aDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235; bDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232; and cDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455 Edited by Dale L. Boger, The Scripps Research Institute, La Jolla, CA, and approved January 15, 2019 (received for review September 27, 2018) Ca2+ leak via ryanodine receptor type 2 (RyR2) can cause poten- heart diseases associated with both atrial and ventricular arrhyth- tially fatal arrhythmias in a variety of heart diseases and has also mia (9). Mutations in RyR2 and its binding partners, which increase + been implicated in neurodegenerative and seizure disorders, mak- SR Ca2 leak, cause primary atrial and ventricular arrhythmia ing RyR2 an attractive therapeutic target for drug development. syndromes such as catecholaminergic polymorphic ventricular Here we synthesized and investigated the fungal natural product tachycardia (CPVT), providing strong evidence for the mechanistic and known insect RyR antagonist (−)-verticilide and several conge- contribution of RyR2 to arrhythmia risk in humans (10). Further ners to determine their activity against mammalian RyR2. Although support comes from gene-targeted mouse models of CPVT, where + the cyclooligomeric depsipeptide natural product (−)-verticilide had catecholamine-induced spontaneous Ca2 release from the SR no effect, its nonnatural enantiomer [ent-(+)-verticilide] signifi- via RyR2 generates potentially fatal cardiac arrhythmias (11, 12).
    [Show full text]
  • Association of Serum S100B, S100A1 and Zinc-Α2
    Progress in Nutrition 2019; Vol. 21, Supplement 1: 154-162 DOI: 10.23751/pn.v21i1-S.5846 © Mattioli 1885 Original articles Association of serum S100B, S100A1 and Zinc-α2- Glycoprotein levels with anthropometric, metabolic and clinical indices in men and women Sorayya Kheirouri1, Mohammad Alizadeh1, Elham Ebrahimi2, Masoumeh Jabbari2 1Associate Professor, Department of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran - Email: kheirouris@tbzmed. ac.ir, [email protected]; 2MSc. student, Department of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran Summary. Objectives: We aimed to investigate serum levels of S100B, S100A1, and Zinc-α2- glycoprotein (ZAG) in men and women and to find association of these proteins with anthropometric, metabolic and clini- cal indices. Methods: Eighty-eight apparently healthy adults, 43 men and 45 women, participated in the study. The participants’ body mass index (BMI), waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) were measured. Serum levels of total cholesterol (TC), triglyceride (TG), low and high den- sity lipoprotein cholesterol (LDL-C and HDL-C), fasting blood sugar (FBS), insulin, S100B, S100A1 and ZAG protein were examined by enzymatic and ELISA laboratory methods. Homeostatic model assessment- insulin resistance (HOMA-IR) index was calculated. Results: Serum levels of S100B, S100A1 and ZAG were comparable between men and women groups. S100B protein was positively associated with TG (r= 0.41, p= 0.006), SBP (r= 0.46, p= 0.002), and DBP (r= 0.37, p= 0.02), but negatively with HDL-c in men. Serum levels of S100A1 were significantly and negatively correlated with WC (r= -0.33, p= 0.03), TG (r= -0.37, p= 0.01), insulin (r= -0.31, p= 0.04) and HOMA-IR (r= -0.32, p= 0.03), in women.
    [Show full text]
  • Transferrin Variants and Conjugates
    (19) TZZ Z ¥ T (11) EP 2 604 623 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 19.06.2013 Bulletin 2013/25 C07K 14/79 (2006.01) A61K 47/48 (2006.01) A61K 38/40 (2006.01) C12N 5/10 (2006.01) (21) Application number: 12189421.6 (22) Date of filing: 08.08.2008 (84) Designated Contracting States: • Friis, Esben Peter AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 2730 Herlev (DK) HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT • Hay, Joanna RO SE SI SK TR Nottingham, Nottinghamshire NG2 6QW (GB) • Finnis, Christopher John Arthur (30) Priority: 08.08.2007 EP 07114012 Nottingham, Nottinghamshire NG7 1JB (GB) 02.04.2008 EP 08153938 (74) Representative: Williams, Rachel Clare (62) Document number(s) of the earlier application(s) in Novozymes Biopharma UK Limited accordance with Art. 76 EPC: Castle Court 08787067.1 / 2 201 036 59 Castle Boulevard Nottingham (71) Applicant: Novozymes Biopharma DK A/S Nottinghamshire NG7 1FD (GB) 2880 Bagsvaerd (DK) Remarks: (72) Inventors: This application was filed on 22-10-2012 as a • Sleep, Darrell divisional application to the application mentioned Nottingham, Nottinghamshire NG2 5DS (GB) under INID code 62. (54) Transferrin variants and conjugates (57) Based on the three-dimensional structure of "thiotransferrin"). The variant polypeptide may be conju- transferrin, the inventors have designed variant polypep- gated through the sulphur atom of the Cysteine residue tides (muteins) which have one or more Cysteine resi- to a bioactive compound. dues with a free thiol group (hereinafter referred to as EP 2 604 623 A2 Printed by Jouve, 75001 PARIS (FR) EP 2 604 623 A2 Description Reference to sequence listing 5 [0001] This application contains a Sequence Listing in computer readable form.
    [Show full text]
  • The Structural Basis for an On–Off Switch Controlling Gβγ-Mediated Inhibition of TRPM3 Channels
    The structural basis for an on–off switch controlling Gβγ-mediated inhibition of TRPM3 channels Marc Behrendta,b,1,2, Fabian Grussc,1,3, Raissa Enzerotha,b, Sandeep Demblaa,b, Siyuan Zhaod, Pierre-Antoine Crassousd, Florian Mohra, Mieke Nysc, Nikolaos Lourose, Rodrigo Gallardoe,4, Valentina Zorzinif,5, Doris Wagnera, Anastassios Economou (Αναστάσιoς Οικoνόμoυ)f, Frederic Rousseaue, Joost Schymkowitze, Stephan E. Philippg, Tibor Rohacsd, Chris Ulensc,6, and Johannes Oberwinklera,b,6 aInstitut für Physiologie und Pathophysiologie, Philipps-Universität Marburg, 35037 Marburg, Germany;bCenter for Mind, Brain and Behavior (CMBB), Philipps-Universität Marburg and Justus-Liebig-Universität Giessen, 35032 Marburg, Germany; cLaboratory of Structural Neurobiology, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium; dDepartment of Pharmacology, Physiology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ 07103; eSwitch Laboratory, VIB Center for Brain and Disease Research, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium; fLaboratory of Molecular Bacteriology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium; and gExperimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, 66421 Homburg, Germany Edited by László Csanády, Semmelweis University, Budapest, Hungary, and accepted by Editorial Board Member David E. Clapham August 27, 2020 (received for review February 13, 2020) TRPM3 channels play important roles in the detection of noxious also subject to inhibition by activated μORsorotherGPCRs(6, heat and in inflammatory thermal hyperalgesia. The activity of 24–28), a process that has been shown to take place in peripheral these ion channels in somatosensory neurons is tightly regulated by endings of nociceptive neurons since locally applied μOR or μ βγ -opioid receptors through the signaling of G proteins, thereby GABA receptor agonists inhibit TRPM3-dependent pain (24–26).
    [Show full text]
  • Exploring the Activity of an Inhibitory Neurosteroid at GABAA Receptors
    1 Exploring the activity of an inhibitory neurosteroid at GABAA receptors Sandra Seljeset A thesis submitted to University College London for the Degree of Doctor of Philosophy November 2016 Department of Neuroscience, Physiology and Pharmacology University College London Gower Street WC1E 6BT 2 Declaration I, Sandra Seljeset, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I can confirm that this has been indicated in the thesis. 3 Abstract The GABAA receptor is the main mediator of inhibitory neurotransmission in the central nervous system. Its activity is regulated by various endogenous molecules that act either by directly modulating the receptor or by affecting the presynaptic release of GABA. Neurosteroids are an important class of endogenous modulators, and can either potentiate or inhibit GABAA receptor function. Whereas the binding site and physiological roles of the potentiating neurosteroids are well characterised, less is known about the role of inhibitory neurosteroids in modulating GABAA receptors. Using hippocampal cultures and recombinant GABAA receptors expressed in HEK cells, the binding and functional profile of the inhibitory neurosteroid pregnenolone sulphate (PS) were studied using whole-cell patch-clamp recordings. In HEK cells, PS inhibited steady-state GABA currents more than peak currents. Receptor subtype selectivity was minimal, except that the ρ1 receptor was largely insensitive. PS showed state-dependence but little voltage-sensitivity and did not compete with the open-channel blocker picrotoxinin for binding, suggesting that the channel pore is an unlikely binding site. By using ρ1-α1/β2/γ2L receptor chimeras and point mutations, the binding site for PS was probed.
    [Show full text]
  • The TRPP2-Dependent Channel of Renal Primary Cilia Also Requires TRPM3
    The TRPP2-dependent channel of renal primary cilia also requires TRPM3 Steven J. Kleene1, Brian J. Siroky2, Julio A. Landero-Figueroa3, Bradley P. Dixon4, Nolan W. Pachciarz2, Lu Lu2, and Nancy K. Kleene1 1Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, Ohio; 2Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; 3Department of Chemistry, University of Cincinnati, Cincinnati, Ohio; 4Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado IntroductIon Primary cilia of renal epithelial cells express several members of the transient receptor potential (TRP) class of cation-conducting channel, including TRPC1, TRPM3, TRPM4, TRPP2, and TRPV4. Some cases of autosomal dominant polycystic kidney disease (ADPKD) are caused by defects in TRPP2 (also called polycystin-2, PC2, or PKD2). A large-conductance, TRPP2- dependent channel in renal cilia has been well described, but it is not known whether this channel includes any other protein subunits. Methods To study this question, we investigated the pharmacology of the TRPP2-dependent channel through electrical recordings from the cilia of mIMCD-3 cells, a murine cell line of renal epithelial origin, results The pharmacology was found to match that of TRPM3 channels. The ciliary TRPP2-dependent channel is known to be activated by depolarization and/or increasing cytoplasmic Ca2+. This activation was greatly enhanced by external pregnenolone sulfate, an agonist of TRPM3 channels. Pregnenolone sulfate did not change the current-voltage relation of the channel. CIM0216, another TRPM3 agonist, modestly increased the activity of the ciliary channels. The channels were effectively blocked by isosakuranetin, a specific inhibitor of TRPM3 channels.
    [Show full text]
  • Interplay Between Gating and Block of Ligand-Gated Ion Channels
    brain sciences Review Interplay between Gating and Block of Ligand-Gated Ion Channels Matthew B. Phillips 1,2, Aparna Nigam 1 and Jon W. Johnson 1,2,* 1 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA; [email protected] (M.B.P.); [email protected] (A.N.) 2 Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA * Correspondence: [email protected]; Tel.: +1-(412)-624-4295 Received: 27 October 2020; Accepted: 26 November 2020; Published: 1 December 2020 Abstract: Drugs that inhibit ion channel function by binding in the channel and preventing current flow, known as channel blockers, can be used as powerful tools for analysis of channel properties. Channel blockers are used to probe both the sophisticated structure and basic biophysical properties of ion channels. Gating, the mechanism that controls the opening and closing of ion channels, can be profoundly influenced by channel blocking drugs. Channel block and gating are reciprocally connected; gating controls access of channel blockers to their binding sites, and channel-blocking drugs can have profound and diverse effects on the rates of gating transitions and on the stability of channel open and closed states. This review synthesizes knowledge of the inherent intertwining of block and gating of excitatory ligand-gated ion channels, with a focus on the utility of channel blockers as analytic probes of ionotropic glutamate receptor channel function. Keywords: ligand-gated ion channel; channel block; channel gating; nicotinic acetylcholine receptor; ionotropic glutamate receptor; AMPA receptor; kainate receptor; NMDA receptor 1. Introduction Neuronal information processing depends on the distribution and properties of the ion channels found in neuronal membranes.
    [Show full text]
  • Glial Protein S100B Modulates Long-Term Neuronal Synaptic Plasticity
    Glial protein S100B modulates long-term neuronal synaptic plasticity Hiroshi Nishiyama*†, Thomas Kno¨ pfel†, Shogo Endo‡, and Shigeyoshi Itohara*§ *Laboratories for Behavioral Genetics and †Neuronal Circuit Dynamics, and ‡Neuronal Circuit Mechanisms Research Group, Brain Science Institute (BSI), Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan Communicated by Richard F. Thompson, University of Southern California, Los Angeles, CA, January 11, 2002 (received for review August 1, 2001) Glial cells are traditionally regarded as elements for structural subject of debate (1). Transgenic mice overexpressing human support and ionic homeostasis, but have recently attracted atten- S100B exhibit impaired hippocampal LTP and spatial learning tion as putative integral elements of the machinery involved in (11). Transgenic mice overexpressing S100B might not be ap- synaptic transmission and plasticity. Here, we demonstrate that propriate for evaluating the physiological roles of S100B, how- calcium-binding protein S100B, which is synthesized in consider- ever, because overexpression of S100B partly mimics patholog- able amounts in astrocytes (a major glial cell subtype), modulates ical conditions in some neuronal diseases, such as Down’s long-term synaptic plasticity. Mutant mice devoid of S100B devel- syndrome and Alzheimer’s disease (12, 13). The constitutive oped normally and had no detectable abnormalities in the cyto- overexpression of S100B might cause chronic neuronal damage architecture of the brain. These mutant mice, however, had (14, 15). Thus, there is no clear consensus regarding the signif- strengthened synaptic plasticity as identified by enhanced long- icance of this glial protein in neuronal synaptic plasticity. term potentiation (LTP) in the hippocampal CA1 region.
    [Show full text]
  • Human Neurophysin II Antibody
    Human Neurophysin II Antibody Monoclonal Mouse IgG2B Clone # 62865 Catalog Number: MAB009 DESCRIPTION Species Reactivity Human Specificity Detects human Neurophysin II in direct ELISAs. Source Monoclonal Mouse IgG2B Clone # 62865 Purification Protein A or G purified from ascites Immunogen Synthetic peptide containing human Neurophysin II Accession # P01186 Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. APPLICATIONS Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website. Recommended Sample Concentration Immunohistochemistry 5-25 µg/mL See Below DATA Immunohistochemistry Neurophysin II in Human Brain Hippocampus Tissue. Neurophysin II was detected in immersion fixed paraffin- embedded sections of human brain hippocampus tissue using Mouse Anti- Human Neurophysin II Monoclonal Antibody (Catalog # MAB009) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent- Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to neurons. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents. PREPARATION AND STORAGE Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (-SP) is shipped with polar packs.
    [Show full text]
  • Molecular Biology of Neuronal Voltage-Gated Calcium Channels
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 30, No 3, 123-130, September 1998 Molecular biology of neuronal voltage-gated calcium channels Hemin Chin and is capable of directing expression of calcium channel activity in heterologous expression systems. In the central Genetics Research Branch, Division of Basic and Clinical Neuroscience Research, nervous system (CNS), VGCCs are expressed by five National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, distinct a1 subunit genes (α1A, α1B, α1C, α1D and α1E), U.S.A. which exhibit further variations due to alternative splicing of the primary RNA transcripts. The α1C and, α1D su b u n i t Accepted 3 August 1998 genes encode dihydropyridine (DHP)-sensitive L-type channels, while the three other α1 subunit genes (α1A, α1B and α1E) give rise to DHP-insensitive P/Q-, N- and R-type channels, respectively. The α2 and δ s u b u n i t proteins are produced by proteolytic cleavage of a larger precursor produced by the single α2-δ gene (Table 1). Introduction Three alternatively spliced variants of the α2 subunit are expressed in a tissue-specific manner. Two variants Calcium ions are important intracellular messengers have been isolated from the brain and skeletal muscle mediating a number of neuronal functions including neuro- (Kim et al., 1992; Williams et al., 1992), and a distinct transmitter release, neurosecretion, neuronal excitation, third splice variant which is expressed in glial cells has survival of eurons, and regulation of gene expression. been recently identified (Puro et al., 1996). In addition to The entry of calcium across the plasmamembrane in the gene encoding the skeletal muscle β subunit, three response to membrane depolarization or activation of 1 other β subunit genes (β2, β3 and β4) have been isolated neurotransmitter receptors represents a major pathway thus far.
    [Show full text]
  • Development and Application of a High-Throughput Luminescent Prophage Induction Assay for the Identification of Temperate Bacter
    Development and application of a high-throughput luminescent prophage induction assay for the identification of temperate bacteriophage-inducing food-grade compounds By Elizabeth Tompkins Food Science and Agricultural Chemistry, McGill University, Sainte-Anne-de-Bellevue, Quebec April 2019 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science in Food Science © Elizabeth Tompkins 2019 Table of Contents Abstract ...........................................................................................................................vi Résumé ......................................................................................................................... viii Acknowledgements .........................................................................................................xi Contribution of authors .................................................................................................. xiii List of tables ...................................................................................................................xv List of figures ................................................................................................................. xvi List of abbreviations ..................................................................................................... xvii Chapter 1: Introduction .................................................................................................... 1 1.1 General introduction .............................................................................................
    [Show full text]